We are one of the few companies in the world carrying out the full cycle of drug manufacturing: from molecular research to the mass production and marketing support.
Our drugs are designed for treatment of the most complicated and socially important diseases such as HIV, hepatitis, multiple sclerosis, etc.
- Three strategic areas: drugs for treatment of infectious, autoimmune, and oncological diseases (priority area)
- The Company has more than 1500 employees, one third of which are scientists and researchers. The main age of the employees is 32.
- Winner of multiple governmental and other awards
- We have offices in the U.S., Brazil, China, India, Singapore and other countries
- Many social and charity projects
- Educational projects, support of young scientists